DOCSLIB.ORG

English → French → English

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
English → French → English Anglais → Français - A - Acetorphine Acétorphine Acetorphine hydrochloride Chlorhydrate d’acétorphine Acetyl-alpha-methylfentanyl Acétyl-alpha-méthylfentanyl Acetyldihydrocodeine Acétyldihydrocodéine Acetyldihydrocodeine hydrochloride Chlorhydrate d’acétyldihydrocodéine Acetylmethadol Acétylméthadol Alfentanil Alfentanil Alfentanil hydrochloride Chlorhydrate d’alfentanil Allobarbital Allobarbital Allobarbital-aminophenazone Allobarbital-aminophénazone Allylprodine Allylprodine Allylprodine hydrochloride Chlorhydrate d’allylprodine Alphacetylmethadol Alphacétylméthadol Alphacetylmethadol hydrochloride Chlorhydrate d’alphacétylméthadol Alphameprodine Alphaméprodine Alphamethadol Alphaméthadol Alpha-methylfentanyl Alpha-méthylfentanyl Alpha-methylfentanyl hydrochloride Chlorhydrate d’alpha-méthylfentanyl Alpha-methylthiofentanyl Alpha-méthylthiofentanyl Alpha-methylthiofentanyl hydrochloride Chlorhydrate d’alpha-méthylthiofentanyl Alphaprodine Alphaprodine Alphaprodine hydrochloride Chlorhydrate d’alphaprodine Alprazolam Alprazolam Amfepramone Amfépramone Amfepramone glutamate Glutamate d’amfépramone Amfepramone hydrochloride Chlorhydrate d’amfépramone Amfepramone resinate Amfépramone résinate Amfetamine Amfétamine Amfetamine acetylsalicylate Acétylsalicylate d’amfétamine Amfetamine adipate Adipate d’amfétamine Amfetamine p-aminophenylacetate Acétate p-aminophényle d’amfétamine Amfetamine aspartate Aspartate d’amfétamine Amfetamine (4-chlorophenoxy) acetate Acétate (chlorophénoxy-4) d’amfétamine Amfetamine hydrochloride Chlorhydrate d’amfétamine Amfetamine pentobarbiturate Pentobarbiturate d’amfétamine Amfetamine phosphate Phosphate d’amfétamine Amfetamine resinate Amfétamine résinate Amfetamine sulfate Sulfate d’amfétamine Amfetamine tannate Tannate d’amfétamine Amfetamine tartrate Tartrate d’amfétamine Amineptine Amineptine Amineptine hydrochloride Chlorhydrate d’amineptine Aminorex Aminorex Aminorex fumarate Fumarate d’aminorex Aminorex hydrochloride Chlorhydrate d’aminorex Amobarbital Amobarbital Amobarbital resinate Amobarbital résinate Amobarbital sodium Amobarbital sodique Anileridine Aniléridine Anileridine dihydrochloride Dichlorhydrate d’aniléridine Anileridine phosphate Phosphate d’aniléridine 521 Anglais → Français - B - Barbital Barbital Barbital calcium Barbital calcique Barbital magnesium Barbital magnésium Barbital sodium Barbital sodique Benzethidine Benzéthidine Benzethidine hydrobromide Bromhydrate de benzéthidine Benzethidine hydrochloride Chlorhydrate de benzéthidine Benzfetamine Benzfétamine Benzfetamine hydrochloride Chlorhydrate de benzfétamine Benzylmorphine Benzylmorphine Benzylmorphine hydrochloride Chlorhydrate de benzylmorphine Benzylmorphine methylsulfonate Méthylsulfonate de benzylmorphine Betacetylmethadol Bétacétylméthadol Beta-hydroxyfentanyl Bêta-hydroxyfentanyl Beta-hydroxyfentanyl hydrochloride Chlorhydrate de bêta-hydroxyfentanyl Beta-hydroxy-3-methylfentanyl Bêta-hydroxy méthyl-3 fentanyl Beta-hydroxy-3-methylfentanyl hydrochloride Chlorhydrate de bêta-hydroxy méthyl-3 fentanyl (+)-cis-beta-hydroxy-3-methylfentanyl Chlorhydrate de (+)-cis-bêta-hydroxy hydrochloride · ¼ H2O méthyl-3 fentanyl · ¼ H2O Betameprodine Bétaméprodine Betamethadol Bétaméthadol Betaprodine Bétaprodine Betaprodine hydrochloride Chlorhydrate de bétaprodine Bezitramide Bézitramide Brolamfetamine (DOB) Brolamfétamine (DOB) Brolamfetamine hydrochloride Chlorhydrate de brolamphétamine Bromazepam Bromazépam Brotizolam Brotizolam Buprenorphine Buprénorphine Buprenorphine hydrochloride Chlorhydrate de buprénorphine Butalbital Butalbital Butobarbital Butobarbital - C - Camazepam Camazépam Cannabis Cannabis Cannabis oil Huile de cannabis Cannabis resin Résine de cannabis Cathine Cathine Cathine hydrochloride Chlorhydrate de cathine Cathine phenobarbital Cathine phénobarbital Cathine resinate Cathine résinate Cathine sulfate Sulfate de cathine Cathinone Cathinone Cathinone hydrochloride Chlorhydrate de cathinone 2C-B 2C-B 2C-B hydrochloride Chlorhydrate de 2C-B Chlordiazepoxide Chlordiazépoxide Chlordiazepoxide dibunate Dibunate de chlordiazépoxide Chlordiazepoxide hydrochloride Chlorhydrate de chlordiazépoxide Clobazam Clobazam 522 Anglais → Français Clonazepam Clonazépam Clonitazene Clonitazène Clonitazene hydrochloride Chlorhydrate de clonitazène Clonitazene methylsulfonate Méthylsulfonate de clonitazène Clorazepate Clorazépate Clorazepate dipotassium Clorazépate dipotassique Clorazepate monopotassium Clorazépate monopotassique Clotiazepam Clotiazépam Cloxazolam Cloxazolam Coca leaf Feuille de coca Cocaine Cocaïne Cocaine benzoate Benzoate de cocaïne Cocaine borate Borate de cocaïne Cocaine citrate Citrate de cocaïne Cocaine formate Formiate de cocaïne Cocaine hydriodide Iodhydrate de cocaïne Cocaine hydrobromide Bromhydrate de cocaïne Cocaine hydrochloride Chlorhydrate de cocaïne Cocaine lactate Lactate de cocaïne Cocaine nitrate Nitrate de cocaïne Cocaine salicylate Salicylate de cocaïne Cocaine sulfate Sulfate de cocaïne Cocaine tartrate Tartrate de cocaïne d-cocaine d-cocaïne Codeine Codéine Codeine acetate Acétate de codéine Codeine camphosulfonate Camphosulfonate de codéine Codeine citrate Citrate de codéine Codeine cyclohexenylethylbarbiturate Cyclohexényléthylbarbiturate de codéine Codeine cyclopentenylallylbarbiturate Cyclopenténylallylbarbiturate de codéine Codeine diallylbarbiturate Diallylbarbiturate de codéine Codeine diethylbarbiturate Diéthylbarbiturate de codéine Codeine glucouronide Glucuronide de codéine Codeine hydriodide Iodhydrate de codéine Codeine hydrobromide Bromhydrate de codéine Codeine hydrochloride Chlorhydrate de codéine Codeine methylbromide Bromométhylate de codéine Codeine phenylethylbarbiturate Phényléthylbarbiturate de codéine Codeine phosphate Phosphate de codéine Codeine resinate Codéine résinate Codeine salicylate Salicylate de codéine Codeine sulfate Sulfate de codéine Codeine-N-oxide N-oxycodéine Codeine-N-oxide hydrochloride Chlorhydrate de N-oxycodéine Codoxime Codoxime Concentrate of poppy straw Concentré de paille de pavot Cyclobarbital Cyclobarbital Cyclobarbital calcium Cyclobarbital calcique - D - Delorazepam Délorazépam Desomorphine Désomorphine Desomorphine hydrobromide Bromhydrate de désomorphine 523 Anglais → Français Desomorphine hydrochloride Chlorhydrate de désomorphine Desomorphine sulfate Sulfate de désomorphine DET DET Diethyltryptamine hydrochloride Chlorhydrate de diéthyltryptamine Dexamfetamine Dexamphétamine Dexamfetamine adipate Adipate de dexamfétamine Dexamfetamine carboxymethylcellulose Dexamfétamine carboxyméthylcellulose Dexamfetamine hydrochloride Chlorhydrate de dexamfétamine Dexamfetamine pentobarbiturate Pentobarbiturate de dexamfétamine Dexamfetamine phosphate Phosphate de dexamfétamine Dexamfetamine resinate Dexamfétamine résinate Dexamfetamine saccharate Saccharate de dexamfétamine Dexamfetamine sulfate Sulfate de dexamfétamine Dexamfetamine tannate Tannate de dexamfétamine Dexamfetamine tartrate Tartrate de dexamfétamine Dextromoramide Dextromoramide Dextromoramide hydrochloride Chlorhydrate de dextromoramide Dextromoramide tartrate Tartrate de dextromoramide Dextropropoxyphene Dextropropoxyphène Dextropropoxyphene hydrochloride Chlorhydrate de dextropropoxyphène Dextropropoxyphene napsylate Napsylate de dextropropoxyphène Dextropropoxyphene resinate Dextropropoxyphène résinate Diampromide Diampromide Diampromide sulfate Sulfate de diampromide Diazepam Diazépam Diethylthiambutene Diéthylthiambutène Diethylthiambutene hydrochloride Chlorhydrate de diéthylthiambutène Difenoxin Difénoxine Difenoxin hydrochloride Chlorhydrate de difénoxine Dihydrocodeine Dihydrocodéine Dihydrocodeine bitartrate Bitartrate de dihydrocodéine Dihydrocodeine hydrochloride Chlorhydrate de dihydrocodéine Dihydrocodeine phosphate Phosphate de dihydrocodéine Dihydrocodeine resinate Dihydrocodéine résinate Dihydrocodeine thiocyanate Thiocyanate de dihydrocodéine Dihydroetorphine Dihydroétorphine Dihydromorphine Dihydromorphine Dihydromorphine hydriodide Iodhydrate de dihydromorphine Dihydromorphine hydrochloride Chlorhydrate de dihydromorphine Dihydromorphine picrate Picrate de dihydromorphine Dimenoxadol Diménoxadol Dimenoxadol hydrochloride Chlorhydrate de diménoxadol Dimepheptanol Dimépheptanol Dimepheptanol hydrochloride Chlorhydrate de dimépheptanol 2,5-dimethoxyamfetamine (DMA) Diméthoxy-2,5 amfétamine (DMA) 2,5-dimethoxyamfetamine hydrochloride Chlorhydrate de diméthoxy-2,5 amfétamine 2,5-dimethoxy-4-ethylamfetamine (DOET) Diméthoxy-2,5 éthyl-4 amfétamine (DOET) 2,5-dimethoxy-4-ethylamfetamine hydrochloride Chlorhydrate de diméthoxy-2,5 éthyl-4 amfétamine Dimethylthiambutene Diméthylthiambutène Dimethylthiambutene hydrochloride Chlorhydrate de diméthylthiambutène Dioxaphetyl butyrate Butyrate de dioxaphétyl Dioxaphetyl butyrate hydrochloride Chlorhydrate de butyrate de dioxaphétyl Diphenoxylate Diphénoxylate Diphenoxylate hydrochloride Chlorhydrate de diphénoxylate 524 Anglais → Français Dipipanone Dipipanone Dipipanone hydrobromide Bromhydrate de dipipanone Dipipanone hydrochloride Chlorhydrate de dipipanone DMHP DMHP DMT DMT Dimethyltryptamine hydrochloride Chlorhydrate de diméthyltryptamine Dimethyltryptamine methyliodide Iodométhylate de diméthyltryptamine Dronabinol Dronabinol Drotebanol Drotébanol - E - Ecgonine Ecgonine Ecgonine benzoylester Ester benzoylique de l’ecgonine Ecgonine benzoylethylester Ester benzoyléthylique de l’ecgonine Ecgonine cinnamoylmethylester Ester cinnamoylméthylique de l’ecgonine Ecgonine 2,6-dimethylbenzoylmethylester Ecgonine 2,6-dimethylbenzoylmethylester
Load more

Recommended publications
  • Did Internet-Purchased Diet Pills Cause Serotonin Syndrome?
    Did Internet-purchased diet pills cause serotonin syndrome? Phentermine also may have increased patient’s neuroleptic malignant syndrome risk s. G, age 28, presents to a tertiary® careDowden hospital Health Media with altered mental status. Six weeks ago she Mstarted taking phentermine, 37.5 mg/d, to lose weight. Her body mass indexCopyright is 24 kg/mFor2 (normal personal range), use only and she obtained the stimulant agent via the Internet. Her family reports Ms. G was very busy in the past week, staying up until 2 AM cleaning. They say she also was irritable with her 5-year-old son. Two days ago, Ms. G complained of fatigue and nausea without emesis. She went to bed early and did not awaken the next morning. Her sister found her in bed, minimally re- DIONISI sponsive to verbal stimuli, and brought her to the hospital. Patients have used phentermine as a weight-reducing IMAGES/SANDRA GETTY agent since the FDA approved this amphetamine-like © compound in 1960.1 Phentermine’s mechanism of ac- tion is thought to involve dopaminergic, noradrenergic, Kyoung Bin Im, MD and serotonergic effects.2 Stimulation of norepineph- Chief resident Internal medicine and psychiatry combined residency program rine (NE) release is its most potent effect, followed Departments of internal medicine and psychiatry by NE reuptake inhibition, stimulation of dopamine Jess G. Fiedorowicz, MD (DA) release, DA reuptake inhibition, stimulation of Associate in psychiatry serotonin (5-HT) release, and 5-HT reuptake inhibition Department of psychiatry (weak).3 Roy J. and Lucille A. Carver College of Medicine Because phentermine could in theory cause serotonin 4 University of Iowa syndrome, its use is contraindicated with monoamine Iowa City oxidase inhibitors (MAOIs) and not recommended with selective serotonin reuptake inhibitors (SSRIs).5 One case report describes an interaction between fl uox- etine and phentermine that appears consistent with se- rotonin syndrome.6 We are aware of no case reports of Current Psychiatry serotonin syndrome caused by phentermine alone.
    [Show full text]
  • Federal Register/Vol. 85, No. 36/Monday, February 24, 2020
    10466 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices Controlled substance Drug code Schedule Alphamethadol ................................................................................................................................................................. 9605 I Benzethidine .................................................................................................................................................................... 9606 I Betacetylmethadol ........................................................................................................................................................... 9607 I Clonitazene ...................................................................................................................................................................... 9612 I Diampromide ................................................................................................................................................................... 9615 I Diethylthiambutene .......................................................................................................................................................... 9616 I Dimethylthiambutene ....................................................................................................................................................... 9619 I Ketobemidone .................................................................................................................................................................
    [Show full text]
  • ESTIMATED WORLD REQUIREMENTS of NARCOTIC DRUGS in GRAMS for 2019 (As of 10 January 2019 )
    ESTIMATED WORLD REQUIREMENTS OF NARCOTIC DRUGS IN GRAMS FOR 2019 (as of 10 January 2019 ) Afghanistan Cannabis 50 Codeine 50 000 Cannabis resin 1 Dextropropoxyphene 10 000 Coca leaf 1 Diphenoxylate 5 000 Cocaine 15 Fentanyl 1 Codeine 650 000 Methadone 20 000 Codeine -N-oxide 1 Morphine 8 000 Dextromoramide 1 Pethidine 90 000 Dextropropoxyphene 200 000 Pholcodine 40 000 Difenoxin 1 Albania Dihydrocodeine 1 Cocaine 1 Diphenoxylate 1 Codeine 1 189 000 Dipipanone 1 Fentanyl 300 Ecgonine 2 Heroin 1 Ethylmorphine 1 Methadone 7 000 Etorphine 1 Morphine 7 800 Fentanyl 17 000 Oxycodone 2 000 Heroin 1 Pethidine 2 700 Hydrocodone 10 000 Pholcodine 1 500 Hydromorphone 4 000 Remifentanil 9 Ketobemidone 1 Sufentanil 2 Levorphanol 1 Algeria Methadone 100 000 Alfentanil 350 Morphine 1 550 000 Codeine 2 500 000 Morphine -N-oxide 1 Etorphine 1 Nicomorphine 1 Fentanyl 500 Norcodeine 1 Methadone 4 000 Normethadone 1 Morphine 9 000 Normorphine 1 Oxycodone 4 000 Opium 10 Pethidine 3 000 Oripavine 1 Pholcodine 1 500 000 Oxycodone 60 000 Remifentanil 1 Oxymorphone 1 Sufentanil 30 Pethidine 50 000 Andorra Phenoperidine 1 Cannabis 2 000 Pholcodine 1 Fentanyl 100 Piritramide 1 Methadone 1 000 Remifentanil 20 000 Morphine 500 Sufentanil 10 Oxycodone 2 000 Thebacon 1 Pethidine 500 Thebaine 70 000 Remifentanil 4 Tilidine 1 Angola Armenia Alfentanil 20 Codeine 3 000 Codeine 21 600 Fentanyl 40 Dextromoramide 188 Methadone 13 500 Dextropropoxyphene 200 Morphine 7 500 Dihydrocodeine 500 Thebaine 15 Diphenoxylate 300 Trimeperidine 1 500 Fentanyl 63 Aruba* Methadone 2 000
    [Show full text]
  • (19) United States (12) Patent Application Publication (10) Pub
    US 20130289061A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0289061 A1 Bhide et al. (43) Pub. Date: Oct. 31, 2013 (54) METHODS AND COMPOSITIONS TO Publication Classi?cation PREVENT ADDICTION (51) Int. Cl. (71) Applicant: The General Hospital Corporation, A61K 31/485 (2006-01) Boston’ MA (Us) A61K 31/4458 (2006.01) (52) U.S. Cl. (72) Inventors: Pradeep G. Bhide; Peabody, MA (US); CPC """"" " A61K31/485 (201301); ‘4161223011? Jmm‘“ Zhu’ Ansm’ MA. (Us); USPC ......... .. 514/282; 514/317; 514/654; 514/618; Thomas J. Spencer; Carhsle; MA (US); 514/279 Joseph Biederman; Brookline; MA (Us) (57) ABSTRACT Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject (21) App1_ NO_; 13/924,815 comprising; administering a therapeutic amount of the neu rological stimulant and administering an antagonist of the kappa opioid receptor; to thereby reduce or prevent the devel - . opment of aversion to the CNS stimulant in the subject. Also (22) Flled' Jun‘ 24’ 2013 disclosed is a method of reducing or preventing the develop ment of addiction to a CNS stimulant in a subj ect; comprising; _ _ administering the CNS stimulant and administering a mu Related U‘s‘ Apphcatlon Data opioid receptor antagonist to thereby reduce or prevent the (63) Continuation of application NO 13/389,959, ?led on development of addiction to the CNS stimulant in the subject. Apt 27’ 2012’ ?led as application NO_ PCT/US2010/ Also disclosed are pharmaceutical compositions comprising 045486 on Aug' 13 2010' a central nervous system stimulant and an opioid receptor ’ antagonist.
    [Show full text]
  • A Bill to Repeal Criminal Drug Laws: Replacing Prohibition with Regulation Joseph L
    Hofstra Law Review Volume 18 | Issue 3 Article 10 1990 A Bill to Repeal Criminal Drug Laws: Replacing Prohibition with Regulation Joseph L. Galiber Follow this and additional works at: http://scholarlycommons.law.hofstra.edu/hlr Part of the Law Commons Recommended Citation Galiber, Joseph L. (1990) "A Bill to Repeal Criminal Drug Laws: Replacing Prohibition with Regulation," Hofstra Law Review: Vol. 18: Iss. 3, Article 10. Available at: http://scholarlycommons.law.hofstra.edu/hlr/vol18/iss3/10 This document is brought to you for free and open access by Scholarly Commons at Hofstra Law. It has been accepted for inclusion in Hofstra Law Review by an authorized administrator of Scholarly Commons at Hofstra Law. For more information, please contact [email protected]. Galiber: A Bill to Repeal Criminal Drug Laws: Replacing Prohibition with R A BILL TO REPEAL CRIMINAL DRUG LAWS: REPLACING PROHIBITION WITH REGULATION Joseph L. Galiber* Conventional wisdom obliges elected officials to beat the narcodrums loudly and incessantly, and to demand increasingly harsh criminal penalties for the sale and use of illegal drugs.' It is reasonable to wonder why I, a senator, would dare submit a bill2 to the New York State Legislature which would regulate all drugs cur- rently proscribed as illegal in precisely the same manner as alcohol.3 The short answer is that the use of the criminal law to control drug use has not, and never will, have anything more than a costly and marginal impact on drug consumption.4 Despite all the public hyperventilation, drug consumption remains a private, consensual * New York State Senator; B.A.
    [Show full text]
  • A Review of Unique Opioids and Their Conversions
    A Review of Unique Opioids and Their Conversions Jacqueline Cleary, PharmD, BCACP Assistant Professor Albany College of Pharmacy and Health Sciences Adjunct Professor SAGE College of Nursing DISCLOSURES • Kaleo • Remitigate, LLC OBJECTIVES • Compare and contrast unique pharmacotherapy options for the treatment of chronic pain including: methadone, buprenoprhine, tapentadol, and tramadol • Select methadone, buprenorphine, tapentadol, or tramadol based on patient specific factors • Apply appropriate opioid conversion strategies to unique opioids • Understand opioid overdose risk surrounding opioid conversions and the use of unique opioids UNIQUE OPIOIDS METHADONE, BUPRENORPHINE, TRAMADOL, TAPENTADOL METHADONE My favorite drug because….? METHADONE- INDICATIONS • FDA labeled indications – (1) chronic pain (2) detoxification Oral soluble tablets for suspension NOT indicated for chronic pain treatment • Initial inpatient detoxification of opioids by a licensed trained provider with methadone and supportive care is appropriate • Methadone maintenance provider must have special credentialing and training as required by state Outpatient prescription must be for pain ONLY and say “for pain” on RX • Continuation of methadone maintenance from outside provider while patient is inpatient for another condition is appropriate http://cdn.atforum.com/wp-content/uploads/SAMHSA-2015-Guidelines-for-OTPs.pdf MECHANISM OF ACTION • Potent µ-opioid agonist • NMDA receptor antagonist • Norepinephrine reuptake inhibitor • Serotonin reuptake inhibitor ADVERSE EVENTS
    [Show full text]
  • Federal Register/Vol. 85, No. 178/Monday, September 14, 2020
    Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices 56631 agreements. All non-confidential DEPARTMENT OF JUSTICE ADDRESSES: Written comments should written submissions will be available for be sent to: Drug Enforcement public inspection at the Office of the Drug Enforcement Administration Administration, Attention: DEA Federal Secretary and on EDIS. [Docket No. DEA–713] Register Representative/DPW, 8701 The Commission vote for these Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must determinations took place on September Importer of Controlled Substances Application: Cerilliant Corporation be sent to: Drug Enforcement 8, 2020. Administration, Attn: Administrator, The authority for the Commission’s AGENCY: Drug Enforcement 8701 Morrissette Drive, Springfield, determination is contained in section Administration, Justice. Virginia 22152. All request for a hearing 337 of the Tariff Act of 1930, as ACTION: Notice of application. should also be sent to: (1) Drug amended (19 U.S.C. 1337), and in Part SUMMARY: Cerilliant Corporation has Enforcement Administration, Attn: 210 of the Commission’s Rules of applied to be registered as an importer Hearing Clerk/OALJ, 8701 Morrissette Practice and Procedure (19 CFR part of basic class(es) of controlled Drive, Springfield, Virginia 22152; and 210). substance(s). Refer to Supplemental (2) Drug Enforcement Administration, Attn: DEA Federal Register By order of the Commission. Information listed below for further Representative/DPW, 8701 Morrissette Issued: September 8, 2020. drug information. DATES: Drive, Springfield, Virginia 22152. Lisa Barton, Registered bulk manufacturers of the affected basic class(es), and SUPPLEMENTARY INFORMATION: In Secretary to the Commission. applicants therefore, may file written accordance with 21 CFR 1301.34(a), this [FR Doc.
    [Show full text]
  • CONTROLLED SUBSTANCE, DRUG, DEVICE and COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun
    CONTROLLED SUBSTANCE, DRUG, DEVICE AND COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun. 23, 2011, P.L. 36, No. 7 Cl. 35 Session of 2011 No. 2011-7 SB 1006 AN ACT Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for Schedule I controlled substances. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Section 4(1) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, amended November 24, 1999 (P.L.894, No.55), is amended to read: Section 4. Schedules of Controlled Substances.--The following schedules include the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. (1) Schedule I--In determining that a substance comes within this schedule, the secretary shall find: a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. The following controlled substances are included in this schedule: (i) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation: 1.
    [Show full text]
  • Amfepramone (Diethylpropion) Elisa Kit Instructions Product #182119, 182116 & 182113 Forensic Use Only
    Neogen Corporation 944 Nandino Blvd., Lexington KY 40511 USA 800/477-8201 USA/Canada | 859/254-1221 Fax: 859/255-5532 | E-mail: [email protected] | Web: www.neogen.com/Toxicology AMFEPRAMONE (DIETHYLPROPION) ELISA KIT INSTRUCTIONS PRODUCT #182119, 182116 & 182113 FORENSIC USE ONLY INTENDED USE: For the determination of trace quantities of Amfepramone (Diethylpropion) and/or other metabolites in human samples. DESCRIPTION Neogen Corporation’s Amfepramone (Diethylpropion) ELISA (Enzyme-Linked Immunosorbent Assay) test kit is a qualitative one-step kit designed for use as a screening device for the detection of drugs and/or their metabolites. The kit was designed for screening purposes and is intended for forensic use only. It is recommended that all suspect samples be confirmed by a quantitative method such as gas chromatography/mass spectrometry (GC/MS). ASSAY PRINCIPLE The Neogen forensic drug detection ELISA is a solid phase immunoassay designed to detect drugs of abuse for forensic application. The test is performed in microwells coated with a high affinity capture antibody. A control or sample is added to the wells followed by an enzyme conjugate. During the following incubation period, the enzyme conjugate competes with the drug in the sample for binding sites on the antibody coated well. After a wash step to remove any unbound material, substrate is added for the color development process. Acid stop solution is added to discontinue the enzyme-substrate reaction. The color intensity is inversely proportional to the amount of drug present in the sample. Therefore, those samples which contain the drug will inhibit binding of the enzyme conjugate to the capture antibody resulting in less color than the negative control.
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • Abecarnil/Allobarbital 959 Pharmacopoeias
    Abecarnil/Allobarbital 959 Pharmacopoeias. In Eur. (see p.vii). acamprosate’s action including inhibition of neuronal hyper- maleate in the treatment of anxiety disorders, hiccups, and nau- Ph. Eur. 6.2 (Acamprosate Calcium). A white or almost white excitability by antagonising excitatory amino acids such as sea and vomiting. Acepromazine, as the base, has also been giv- powder. Freely soluble in water; practically insoluble in alcohol glutamate. en in preparations for the management of insomnia. and in dichloromethane. A 5% solution in water has a pH of 5.5 1. Wilde MI, Wagstaff AJ. Acamprosate: a review of its pharmacol- Preparations to 7.0. ogy and clinical potential in the management of alcohol depend- ence after detoxification. Drugs 1997; 53: 1038–53. Proprietary Preparations (details are given in Part 3) Adverse Effects 2. Anonymous. Acamprosate for alcohol dependence? Drug Ther Denm.: Plegicil; Turk.: Plegicil. The main adverse effect of acamprosate is dosage-related diar- Bull 1997; 35: 70–2. Multi-ingredient: Fr.: Noctran. rhoea; nausea, vomiting, and abdominal pain occur less frequent- 3. Mason BJ. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review. J Clin Psychiatry 2001; 62 (suppl ly. Other adverse effects have included pruritus, and occasionally 20): 42–8. a maculopapular rash; bullous skin reactions have occurred rare- 4. Overman GP, et al. Acamprosate for the adjunctive treatment of Aceprometazine (rINN) ly. Depression and fluctuations in libido have also been reported. alcohol dependence. Ann Pharmacother 2003; 37: 1090–9. Hypersensitivity reactions including urticaria, angioedema, and 5. Anton RF, et al. Combined pharmacotherapies and behavioral 16-64 CB; Aceprometazina; Acéprométazine; Aceprometazi- anaphylaxis have been reported very rarely.
    [Show full text]
  • Smumedical Journal
    SMU Medical Journal ISSN : 2349 – 1604 (Volume – 4, No. 1, January 2017) Review Article Indexed in SIS (USA), ASI (Germany), I2OR & i-Scholar (India), SJIF (Morocco) and Cosmos Foundation (Germany) databases. Impact Factor: 3.835 (SJIF) Analytical Aspects with Brief Overview of Depressants Sandeep Kumar1 Nand Gopal Giri2 Ashok Kumar Jaiswal3* Anil Kumar Jaiswal4 1M.Sc. (Forensic Science), LNJN NICFS, New Delhi 110085, 2Assistant Professor, Department of Chemistry, Shivaji College (University of Delhi) Raja Garden, New Delhi 110 027, 3Dept. of Forensic Medicine and toxicology, All India institute of Medical Sciences, New Delhi 110 029.4Assistant Professor, Department of Mathematics, St. Andrew’s PG College, Gorakhpur, UP. *Corresponding author Manuscript received : 30.10.2016 Manuscript accepted: 21.11.2016 Abstract Depressants are drugs that slow down the functions of the central nervous system (CNS). These drugs are used to reduce anxiety and insomnia without drowsiness. The depressants cause relaxed feeling if used in small quantity but cause unconsciousness, vomiting and even death if taken in high quantity. It affects concentration and coordination of a person by slowing down his/ her ability to respond in unexpected situations. These drugs are also attributed for their physiological and psychological effects, eventually in large dose it become lethal. The different 142 SMU Medical Journal, Volume – 4, No. – 1, January, 2017 physical and chemical features of some very often used depressants are discussed in this manuscript. Keyword: Depressant, TLC, UV spectroscopy, HPLC, GLC etc. Introduction The classical depressants are hypnotics (which induce sleep), most antianxiety medicine (diazepam or valium), muscle spasm prevent seizure, but these drugs rapidly develop dependence and tolerance which finally leads to coma and death, so use of these drugs is highly unsafe.
    [Show full text]